Natural Biocon (India) Share Price
3.20-0.02 (-0.62%)
-49.53% past 1 Year
Corporate filings & documents
Announcements
As per Attachment
1 week agoAs per Attachment
1 week agoAGM
2 weeks agoAGM
2 weeks agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve AGM
2 weeks agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve AGM
2 weeks agoQuarterly Results June 30 2026
1 month agoQuarterly Results June 30 2026
1 month agoQuarterly Results June 30 2026
1 month agoQuarterly Results June 30 2026
1 month agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Quarterly Results June 30 2026
1 month agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Quarterly Results June 30 2026
1 month agoResignation of Directors
2 months agoResignation of Directors
2 months agoReg 74(5)
2 months agoReg 74(5)
2 months agoClosure of Trading Window
3 months agoClosure of Trading Window
3 months agoAGM
3 months agoAGM
3 months agoAppointment of Ms. Shruti Sharma (M. No.: A52723) as Company Secretary and Compliance Officer of the Company w.e.f. 05th June 2026.
3 months agoAppointment of Ms. Shruti Sharma (M. No.: A52723) as Company Secretary and Compliance Officer of the Company w.e.f. 05th June 2026.
3 months agoReg 24A
3 months agoReg 24A
3 months agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/06/2026 inter alia to consider and approve Details related to AGM
3 months agoUnable to conduct Board Meeting on 18th May 2026
3 months agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider and approve AGM
4 months agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider and approve AGM
4 months agoAudited Financial Results for the Quarter and Year ended March 2026
4 months agoAudited Financial Results along with Auditors Report for the Quarter and Year ended March 2026
4 months agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2026 inter alia to consider and approve Audited Results and Audit Report
4 months agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2026 inter alia to consider and approve Audited Results and Audit Report
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Natural Biocon (India) Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24299GJ1992PLC018210</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Gopal Trivedi <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Arunkumar Prajapati <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 28/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 inter alia to consider and approve Audited Financial Result for the Quarter and Financial Year Ended on 31st March 2026 along with the Auditors Report.
5 months agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 inter alia to consider and approve Audited Financial Result for the Quarter and Financial Year Ended on 31st March 2026 along with the Auditors Report.
5 months agoCertificate under Reg 74(5)
5 months agoClosure of Trading Window
6 months agoClosure of Trading Window
6 months agoIndependent Directors Meeting
6 months agoIndependent Directors Meeting
6 months agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2026 inter alia to consider and approve Independent Directors Meeting
6 months agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2026 inter alia to consider and approve Independent Directors Meeting
6 months agoUn-Audited Financial Results for the Third quarter and Nine months ended December 31 2025 along with the Statutory Auditors Limited Review Report.
7 months agoUn-Audited Financial Results for the Third quarter and Nine months ended December 31 2025 along with the Statutory Auditors Limited Review Report.
7 months agoUn-Audited Financial Results (UFR) for the Third quarter and Nine Months ended December 31 2025 along with the Statutory Auditors Limited Review Report.
7 months agoUn-Audited Financial Results (UFR) for the Third quarter and Nine Months ended December 31 2025 along with the Statutory Auditors Limited Review Report.
7 months agoNatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Unaudited financial result for the Third Quarter ended on 31st December 2025 along with the Auditors Limited Review Report.
7 months agoCertificate under Reg 74(5) of SEBI for quarter ended on December 31 2025
8 months agoIntimation for closure of trading window
8 months agoRevised Financial Result for the quarter ended September 30 2025.
9 months agoAnnual reports
Concalls & investor presentations
No presentations found